A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. (Q39507890)
Jump to navigation
Jump to search
scientific article published on 28 April 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. |
scientific article published on 28 April 2015 |
Statements
A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants (English)
M Tameris
D A Hokey
V Nduba
F Laher
G Kiringa
K Gondo
E M Lazarus
G E Gray
S Nachman
H Mahomed
K Downing
B Abel
T J Scriba
J B McClain
M G Pau
J Hendriks
V Dheenadhayalan
S Ishmukhamedov
H Geldenhuys
B Shepherd
G Blatner
V Cardenas
R Walker
W A Hanekom
J Sadoff
M Douoguih
L Barker
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference